Fig. 7From: Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplayA schematic diagram showing the roles of VEGF-IL6-STAT3 axis in the HSCs-CRC interplay; and the mechanism underlying the inhibitory effect of brevilin A on CRC liver metastasisBack to article page